Startup India Government of India
Mekanar Pharma Private Limited - pharma in Hyderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹3.2 Cr
▲ 50% YoY
Net profit · FY 2025
₹2.17 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹13.79 Lakh
EBITDA margin 4.3%
Authorised capital
₹50 Lakh
Registered with MCA
Paid-up capital
₹27.5 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Employees · EPFO
10
Provident fund records
Directors on board
3
As per MCA filings
About Mekanar Pharma Private Limited
Data last updated:
Mekanar Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, recognised as a startup by DPIIT. It operates in the pharma contract r and d segment of the pharmaceuticals sector. It was incorporated on 09 June 2022.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24304TG2022PTC163523. Its GSTIN is 36AAPCM8644L1ZN (Telangana).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹27.5 Lakh. It is led by directors including Srinivasa Rao Metta (Managing Director) and Jwala Srinivasa Phani Krishna Darsi (Whole-Time Director).
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 1st Floor No.C – 7 Ida Moula – Ali Malkajgiri(M) Medchal Dist, Hyderabad, Telangana, India – 500040.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.2 Cr, a growth of 50% compared to the previous year. For the same year it recorded a net profit of ₹2.17 Lakh (net margin 0.7%) and EBITDA of ₹13.79 Lakh (EBITDA margin 4.3%).
The company has about 10 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Mekanar Pharma.
Mekanar Pharma Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-20-0037597). For more details, the company can be reached via its website mekanarpharma.com.
Company details
CIN U24304TG2022PTC163523
Registration Number 163523
Incorporation Date 09 June 2022
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 27 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-TS-20-0037597
Key People
Srinivasa Rao Metta Managing Director Jwala Srinivasa Phani Krishna Darsi Whole-Time Director Kathyayini Pasthula Whole-Time Director Recognitions & Rankings of Mekanar Pharma
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-TS-20-0037597
Contact details
Mekanar Pharma Private Limited's registered office is in Hyderabad, Telangana. Its website is mekanarpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address1st Floor No.C – 7 Ida Moula – Ali Malkajgiri(M) Medchal Dist, Hyderabad, Telangana, India – 500040
- IndustryPharma, Pharma Contract R&D, API Manufacturers
To see the full contact details of Mekanar Pharma Private Limited, buy the company report.
Comprehensive company report
Mekanar Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Mekanar Pharma operates one associated brand: Mekanar Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Offers contract services for API development, manufacturing, and research globally. | mekanarpharma.com |
Business activity
The main business activity of Mekanar Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Mekanar Pharma Private Limited, buy the company report.
Financials of Mekanar Pharma Private Limited
FY 2025 filings availableMekanar Pharma Private Limited reported revenue of ₹3.2 Cr (up 50% YoY) for FY 2025.
Revenue · FY 2025
₹3.2 Cr ▲ 50%
Net profit · FY 2025
₹2.17 Lakh margin 0.7%
EBITDA · FY 2025
₹13.79 Lakh margin 4.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 50%
EBITDA CAGR growth
1 year
▲ 212%
Revenue rose 50% in the latest year. EBITDA rose 212% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹13.79 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹2.17 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 4.3% | ||
| Net Profit Margin | 0.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Mekanar Pharma Private Limited, buy the company report.
Board of directors of Mekanar Pharma Private Limited
Mekanar Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jwala Srinivasa Phani Krishna Darsi | Whole-Time Director | 09 Jun 2022 | 4 Years 4 Months | Current |
| Kathyayini Pasthula | Whole-Time Director | 09 Jun 2022 | 4 Years 4 Months | Current |
| Srinivasa Rao Metta | Managing Director | 09 Jun 2022 | 4 Years 4 Months | Current |
Peer comparison
Mekanar Pharma Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pyrrhic Pharma Private Limited | ₹3.27 Cr (FY 2025) | 152.0% | Mehsana, Gujarat, India | |||
| Abhelfen Life Science Private Limited | ₹3.23 Cr (FY 2025) | 404.0% | Gandhinagar, Gujarat, India | |||
| Maruti Futuristic Pharma Private Limited | ₹3.2 Cr (FY 2025) | -25.0% | Bangalore, Karnataka, India | |||
| Mekanar Pharma Private Limitedthis company | ₹3.2 Cr (FY 2025) | ₹2.17 Lakh | 0.7% | 50.0% | 10 | Hyderabad, Telangana, India |
| Cil Laboratories Private Limited | ₹3.14 Cr (FY 2023) | 26590.0% | Kolkata, West Bengal, India | |||
| Vvic Pharma Private Limited | ₹3.14 Cr (FY 2025) | 303.0% | Ankleshwar, Gujarat, India | |||
| Sthree Chemicals Private Limited | ₹3.11 Cr (FY 2024) | -53.0% | Walajapet, Tamil Nadu, India | |||
| Supreme Drugs Private Limited | ₹3.08 Cr (FY 2024) | 1350.0% | Banaskatha, Gujarat, India |
To see the full peer comparison of Mekanar Pharma Private Limited, buy the company report.
Auditor
Mekanar Pharma Private Limited is audited by G.NARAYANAREDDY& ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G.NARAYANAREDDY& ASSOCIATES | FY 2023 | 010738S |
Shareholding
The shareholding of Mekanar Pharma Private Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Mekanar Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mekanar Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mekanar Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Mekanar Pharma Private Limited has a workforce of 10 employees on its EPFO records as of Mar 30, 2024, across 1 active EPFO establishment.
Employee count
10
Active EPFO establishments
1
Employee growth
66.67%
GST
Mekanar Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAPCM8644L1ZN | Telangana | Active | 03 Sep 2022 |
To see the full GST registrations and return filing status of Mekanar Pharma Private Limited, buy the company report.
Recent activity
Mekanar Pharma Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Nageswara Rao Mekala ceased to be Additional Director on 16 Sep 2023.
AGM
Mekanar Pharma Private Limited last Annual general meeting of members was held on 27 Sep 2025 as per latest MCA records.
Filing
Mekanar Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Ceased
Nageswara Rao Mekala ceased to be Additional Director.
Appointed
Jwala Srinivasa Phani Krishna Darsi was appointed as Whole-Time Director.
Appointed
Kathyayini Pasthula was appointed as Whole-Time Director.
Appointed
Srinivasa Rao Metta was appointed as Managing Director.
Incorporation
09 Jun 2022
Mekanar Pharma Private Limited was registered on 09 Jun 2022 with Roc Hyderabad & aged 4 years 4 months as per MCA records.
Frequently asked questions
Mekanar Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharma contract r and d, within the pharma industry. It was incorporated on 09 June 2022 (4+ years old) and is registered under CIN U24304TG2022PTC163523.
Mekanar Pharma has 3 current directors:
- Srinivasa Rao Metta - Managing Director
- Jwala Srinivasa Phani Krishna Darsi - Whole-Time Director
- Kathyayini Pasthula - Whole-Time Director
The latest financial statements of Mekanar Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Mekanar Pharma is 36AAPCM8644L1ZN, registered in Telangana.
The CIN (Corporate Identification Number) of Mekanar Pharma is U24304TG2022PTC163523. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mekanar Pharma was incorporated on 09 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Mekanar Pharma by revenue are Pyrrhic Pharma Private Limited, Abhelfen Life Science Private Limited, Maruti Futuristic Pharma Private Limited, Cil Laboratories Private Limited, Vvic Pharma Private Limited and 2 more, all in the Pharma industry (API Manufacturers, Contract Research), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Nageswara Rao Mekala ceased to be Additional Director on 16 Sep 2023. Jwala Srinivasa Phani Krishna Darsi was appointed as Whole-Time Director on 09 Jun 2022. Kathyayini Pasthula was appointed as Whole-Time Director on 09 Jun 2022. Mekanar Pharma has 4 board changes on record in total.
Yes, Mekanar Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Mekanar Pharma is registered as a micro enterprise under Udyam registration (number: UDYAM-TS-20-0037597).
Mekanar Pharma can be reached through the website mekanarpharma.com. Its registered office is in Hyderabad, Telangana, India.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages